Fol. Biol. 2019, 65, 188-194

https://doi.org/10.14712/fb2019065040188

Strong Association between APOA5 Gene Polymorphisms and Hypertriglyceridaemic Episodes

Michal Vrablík1, J. A. Hubáček2, D. Dlouha2, M. Satny1, V. Adámková3, R. Ceska1

13rd Department of Internal Medicine, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
2Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
3Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

Received May 2019
Accepted May 2019

References

1. Arsenault, B. J., Boekholdt, S. M., Kastelein, J. J. (2011) Lipid parameters for measuring risk of cardiovascular disease. Nat. Rev. Cardiol. 8, 197-206. <https://doi.org/10.1038/nrcardio.2010.223>
2. Cífková, R., Skodová, Z., Bruthans, J., Adámková, V., Jozífová, M., Galovcová, M., Wohlfahrt, P., Krajcoviechová, A., Poledne, R., Stávek, P., Lánská, V. (2010) Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Atherosclerosis 211, 676-681. <https://doi.org/10.1016/j.atherosclerosis.2010.04.007>
3. Day, I. N., Humphries, S. E. (1994) Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Anal. Biochem. 222, 389-395. <https://doi.org/10.1006/abio.1994.1507>
4. Dlouhá, D., Hubáček, J. A. (2017) Regulatory RNAs and cardiovascular disease – with a special focus on circulating microRNAs. Physiol. Res. 66(Suppl. 1), S21-S38. <https://doi.org/10.33549/physiolres.933588>
5. Domínguez-Reyes, T., Astudillo-López, C. C., Salgado-Goytia, L., Muñoz-Valle, J. F., Salgado-Bernabé, A. B., Guzmán-Guzmán, I. P., Castro-Alarcón, N., Moreno- Godínez, M. E., Parra-Rojas, I. (2015) Interaction of dietary fat intake with APOA2, APOA5 and LEPR polymorphisms and its relationship with obesity and dyslipidemia in young subjects. Lipids Health Dis. 14, 106. <https://doi.org/10.1186/s12944-015-0112-4>
6. Ganesan, A. (2018) Epigenetics: the first 25 centuries. Philos. Trans. R. Soc. Lond. B Biol. Sci. 373, (1748).
7. Guardiola, M., Ribalta, J. (2017) Update on APOA5 genetics: toward a better understanding of its physiological impact. Curr. Atheroscler. Rep. 19, 30. <https://doi.org/10.1007/s11883-017-0665-y>
8. Horínek, A., Vrablík, M., Ceska, R., Adámková, V., Poledne, R., Hubacek, J. A. (2003) T-1131→C polymorphism within the apolipoprotein AV gene in hypertriglyceridemic individuals. Atherosclerosis 167, 369-370. <https://doi.org/10.1016/S0021-9150(03)00022-4>
9. Hubacek, J. A., Skodová, Z., Adámková, V., Lánská, V., Poledne, R. (2004) The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction. Clin. Genet. 65, 126-130. <https://doi.org/10.1111/j.0009-9163.2004.00199.x>
10. Hubacek, J. A. (2005) Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants. Clin. Chem. Lab. Med. 43, 897-902. <https://doi.org/10.1515/CCLM.2005.153>
11. Hubacek, J. A., Lánská, V., Skodová, Z., Adámková, V., Poledne, R. (2008) Sex-specific interaction between APOE and APOA5 variants and determination of plasma lipid levels. Eur. J. Hum. Genet. 16, 135-138. <https://doi.org/10.1038/sj.ejhg.5201941>
12. Hubáček, J. A., Staněk, V., Gebauerová, M., Poledne, R., Aschermann, M., Skalická, H., Matoušková, J., Kruger, A., Pěnička, M., Hrabáková, H., Veselka, J., Hájek, P., Lánská, V., Adámková, V., Pitha, J. (2012) Association between a marker on chromosome 9 and acute coronary syndrome. Confirmatory study on Czech population. Folia Biol. (Praha) 58, 203-208.
13. Hubacek, J. A., Peasey, A., Kubinova, R., Pikhart, H., Bobak, M. (2014) The association between APOA5 haplotypes and plasma lipids is not modified by energy or fat intake: the Czech HAPIEE study. Nutr. Metab. Cardiovasc. Dis. 24, 243-247. <https://doi.org/10.1016/j.numecd.2013.08.008>
14. Hubáček, J. A., Pikhart, H., Peasey, A., Kubínová, R., Bobák, M. (2015) Nobody is perfect: comparison of the accuracy of PCR-RFLP and KASP™ method for genotyping. ADH1B and FTO polymorphisms as examples. Folia Biol. (Praha) 61, 156-160.
15. Hubacek, J. A. (2016) Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiology. Gene 592, 193-199. <https://doi.org/10.1016/j.gene.2016.07.070>
16. Hubacek, J. A., Adamkova, V., Lanska, V., Dlouha, D. (2017a) Polygenic hypercholesterolemia: examples of GWAS results and their replication in the Czech-Slavonic population. Physiol. Res. 66(Suppl. 1), S101-S111. <https://doi.org/10.33549/physiolres.933580>
17. Hubacek, J. A., Stanek, V., Gebauerova, M., Adamkova, V., Lesauskaite, V., Zaliaduonyte-Peksiene, D., Tamosiunas, A., Supiyev, A., Kossumov, A., Zhumadilova, A., Pitha, J. (2017b) Traditional risk factors of acute coronary syndrome in four different male populations - total cholesterol value does not seem to be relevant risk factor. Physiol. Res. 66(Suppl. 1), S121-S128. <https://doi.org/10.33549/physiolres.933597>
18. Hubacek, J. A. (2018) Basis of genetic determination of civilization diseases. Postgrad. Med. 20(Suppl 1), 6-10. (in Czech)
19. Johansen, C. T., Hegele, R. A. (2011) Genetic bases of hypertriglyceridemic phenotypes. Curr. Opin. Lipidol. 22, 247-253. <https://doi.org/10.1097/MOL.0b013e3283471972>
20. Kathiresan, S., Willer, C. J., Peloso, G. M., Demissie, S., Musunuru, K., Schadt, E. E., Kaplan, L., Bennett, D., Li, Y., Tanaka, T., Voight, B. F., Bonnycastle, L. L., Jackson, A. U., Crawford, G., Surti, A., Guiducci, C., Burtt, N. P., Parish, S., Clarke, R., Zelenika, D., Kubalanza, K. A., Morken, M. A., Scott, L. J., Stringham, H. M., Galan, P., Swift, A. J., Kuusisto, J., Bergman, R. N., Sundvall, J., Laakso, M., Ferrucci, L., Scheet, P., Sanna, S., Uda, M., Yang, Q., Lunetta, K. L., Dupuis, J., de Bakker, P. I., O‘Donnell, C. J., Chambers, J. C., Kooner, J. S., Hercberg, S., Meneton, P., Lakatta, E. G., Scuteri, A., Schlessinger, D., Tuomilehto, J., Collins, F. S., Groop, L., Altshuler, D., Collins, R., Lathrop, G. M., Melander, O., Salomaa, V., Peltonen, L., Orho-Melander, M., Ordovas, J. M., Boehnke, M., Abecasis, G. R., Mohlke, K. L., Cupples, L .A. (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56-65. <https://doi.org/10.1038/ng.291>
21. Ladd-Acosta, C., Fallin, M. D. (2016) The role of epigenetics in genetic and environmental epidemiology. Epigenomics 8, 271-283. <https://doi.org/10.2217/epi.15.102>
22. Lai, C. Q., Wojczynski, M. K., Parnell, L. D., Hidalgo, B. A., Irvin, M. R., Aslibekyan, S., Province, M. A., Absher, D. M., Arnett, D. K., Ordovás, J. M. (2016) Epigenome-wide association study of triglyceride postprandial responses to a high-fat dietary challenge. J. Lipid Res. 57, 2200-2207. <https://doi.org/10.1194/jlr.M069948>
23. Lin, E., Kuo, P. H., Liu, Y. L., Yang, A. C., Tsai, S. J. (2017) Detection of susceptibility loci on APOA5 and COLEC12 associated with metabolic syndrome using a genome-wide association study in a Taiwanese population. Oncotarget 8, 93349-93359. <https://doi.org/10.18632/oncotarget.20967>
24. Lin, E., Kuo, P. H., Liu, Y. L., Yang, A. C., Kao, C. F., Tsai, S. J. (2016) Association and interaction of APOA5, BUD13, CETP, LIPA and health-related behavior with metabolic syndrome in a Taiwanese population. Sci. Rep. 6, 36830. <https://doi.org/10.1038/srep36830>
25. Liu, J., Zeng, F. F., Liu, Z. M., Zhang, C. X., Ling, W. H., Chen, Y. M. (2013) Effects of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studies. Lipids Health Dis. 12, 159. <https://doi.org/10.1186/1476-511X-12-159>
26. Liu, X., Huang, G., Niu, Z., Wei, Y., Wang, R. (2018) Habitual aerobic exercise, gene APOA5 named rs662799 SNP and response of blood lipid and lipoprotein phenotypes among older Chinese adult. Exp. Gerontol. 110, 46-53. <https://doi.org/10.1016/j.exger.2018.05.007>
27. Maher, B. S. (2015) Polygenic scores in epidemiology: risk prediction, etiology, and clinical utility. Curr. Epidemiol. Rep. 2, 239-244. <https://doi.org/10.1007/s40471-015-0055-3>
28. Melegh, B. I., Duga, B., Sümegi, K., Kisfali, P., Maász, A., Komlósi, K., Hadzsiev, K., Komoly, S., Kosztolányi, G., Melegh, B. (2012) Mutations of the apolipoprotein A5 gene with inherited hypertriglyceridaemia: review of the current literature. Curr. Med. Chem. 19, 6163-6170. <https://doi.org/10.2174/0929867311209066163>
29. Merkel, M., Heeren, J. (2005) Give me A5 for lipoprotein hydrolysis! J. Clin. Invest. 115, 2694-2696. <https://doi.org/10.1172/JCI26712>
30. Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., Lennie, T. A., Levi, M., Mazzone, T., Pennathur, S.; American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease (2011) Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 123, 2292-2333. <https://doi.org/10.1161/CIR.0b013e3182160726>
31. Miller, S. A., Dykes, D. D., Polesky, H. F. (1988) A simple salting out procedure for DNA extraction from human nucleated cells. Nucleic Acids Res. 16, 1215. <https://doi.org/10.1093/nar/16.3.1215>
32. Moore, L. D., Le, T., Fan, G. (2013) DNA methylation and its basic function. Neuropsychopharmacology 38, 23-38. <https://doi.org/10.1038/npp.2012.112>
33. Nilsson, S. K., Heeren, J., Olivecrona, G., Merkel, M. (2011) Apolipoprotein A-V; a potent triglyceride reducer. Atherosclerosis 219, 15-21. <https://doi.org/10.1016/j.atherosclerosis.2011.07.019>
34. O’Brien, P. J., Alborn, W. E., Sloan, J. H., Ulmer, M., Boodhoo, A., Knierman, M. D., Schultze, A. E., Konrad, R. J. (2005) The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin. Chem. 5, 351-359. <https://doi.org/10.1373/clinchem.2004.040824>
35. Oliva, I., Guardiola, M., Vallvé, J. C., Ibarretxe, D., Plana, N., Masana, L., Monk, D., Ribalta, J. (2016) APOA5 genetic and epigenetic variability jointly regulate circulating triacylglycerol levels. Clin. Sci. (Lond) 130, 2053-2059. <https://doi.org/10.1042/CS20160433>
36. Pennacchio, L. A., Olivier, M., Hubacek, J. A., Cohen, J. C., Cox, D. R., Fruchart, J. C., Krauss, R. M., Rubin, E. M. (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294, 169-173. <https://doi.org/10.1126/science.1064852>
37. Pennacchio, L. A., Olivier, M., Hubacek, J. A., Krauss, R. M., Rubin, E. M., Cohen, J. C. (2002) Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum. Mol. Genet. 11, 3031-3038. <https://doi.org/10.1093/hmg/11.24.3031>
38. Pikhart, H., Hubáček, J. A., Peasey, A., Kubínová, R., Bobák, M. (2015) Association between fasting plasma triglycerides, all-cause and cardiovascular mortality in Czech population. Results from the HAPIEE study. Physiol. Res. 64(Suppl 3), S355-S361. <https://doi.org/10.33549/physiolres.933179>
39. Sánchez-Moreno, C., Ordovás, J. M., Smith, C. E., Baraza, J. C., Lee, Y. C., Garaulet, M. (2011) APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population. J. Nutr. 141, 380-385. <https://doi.org/10.3945/jn.110.130344>
40. Schwarzova, L., Hubacek, J. A., Vrablik, M. (2015) Genetic predisposition of human plasma triglyceride concentrations. Physiol. Res. 64 (Suppl 3), S341-S354. <https://doi.org/10.33549/physiolres.933197>
41. Shirts, B. H., Howard, M. T., Hasstedt, S. J., Nanjee, M. N., Knight, S., Carlquist, J. F., Anderson, J. L., Hopkins, P. N., Hunt, S. C. (2012) Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterol. Atherosclerosis 222, 167-174. <https://doi.org/10.1016/j.atherosclerosis.2012.02.030>
42. Smith, J. A., Ware, E. B., Middha, P., Beacher, L., Kardia, S. L. (2015) Current applications of genetic risk scores to cardiovascular outcomes and subclinical phenotypes. Curr. Epidemiol. Rep. 2, 180-190. <https://doi.org/10.1007/s40471-015-0046-4>
43. Son, K. Y., Son, H. Y., Chae, J., Hwang, J., Jang, S., Yun, J. M., Cho, B., Park, J. H., Kim, J. I. (2015) Genetic association of APOA5 and APOE with metabolic syndrome and their interaction with health-related behavior in Korean men. Lipids Health Dis. 14, 105. <https://doi.org/10.1186/s12944-015-0111-5>
44. Sousa, M. O., Alía, P., Pintó, X., Corbella, E., Navarro, M. A. (2008) Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia. Clin. Chim. Acta 395, 68-71. <https://doi.org/10.1016/j.cca.2008.05.009>
45. Suchanek, P., Lorenzova, A., Poledne, R., Hubacek, J. A. (2008) Changes of plasma lipids during weight reduction in females depends on APOA5 variants. Ann. Nutr. Metab. 53, 104-108. <https://doi.org/10.1159/000165358>
46. Talmud, P. J., Hawe, E., Martin, S., Olivier, M., Miller, G. J., Rubin, E. M., Pennacchio, L. A., Humphries, S. E. (2002) Relative contribution of variation within the APOC3/A4/ A5 gene cluster in determining plasma triglycerides. Hum. Mol. Genet. 11, 3039-3046. <https://doi.org/10.1093/hmg/11.24.3039>
47. Talmud, P. J., Cooper, J. A., Morris, R. W., Dudbridge, F., Shah, T., Engmann, J., Dale, C., White, J., McLachlan, S., Zabaneh, D., Wong, A., Ong, K. K., Gaunt, T., Holmes, M. V., Lawlor, D. A., Richards, M., Hardy, R., Kuh, D., Wareham, N., Langenberg, C., Ben-Shlomo, Y., Wannamethee, S. G., Strachan, M. W., Kumari, M., Whittaker, J. C., Drenos, F., Kivimaki, M., Hingorani, A. D., Price, J. F., Humphries, S. E.; UCLEB Consortium. (2015) Sixty-five common genetic variants and prediction of type 2 diabetes. Diabetes 64, 1830-1840. <https://doi.org/10.2337/db14-1504>
48. Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., Johansen, C. T., Fouchier, S. W., Isaacs, A., Peloso, G. M., Barbalic, M., Ricketts, S. L., Bis, J. C., Aulchenko, Y. S., Thorleifsson, G., Feitosa, M. F., Chambers, J., Orho-Melander, M., Melander, O., Johnson, T., Li, X., Guo, X., Li, M., Shin Cho, Y., Jin Go, M., Jin Kim, Y., Lee, J. Y., Park, T., Kim, K., Sim, X., Twee-Hee Ong, R., Croteau-Chonka, D. C., Lange, L. A., Smith, J. D., Song, K., Hua Zhao, J., Yuan, X., Luan, J., Lamina, C., Ziegler, A., Zhang, W., Zee, R. Y., Wright, A. F., Witteman, J. C., Wilson, J. F., Willemsen, G., Wichmann, H. E., Whitfield, J. B., Waterworth, D. M., Wareham, N. J., Waeber, G., Vollenweider, P., Voight, B. F., Vitart, V., Uitterlinden, A. G., Uda, M., Tuomilehto, J., Thompson, J. R., Tanaka, T., Surakka, I., Stringham, H. M., Spector, T. D., Soranzo, N., Smit, J. H., Sinisalo, J., Silander, K., Sijbrands, E. J., Scuteri, A., Scott, J., Schlessinger, D., Sanna, S., Salomaa, V., Saharinen, J., Sabatti, C., Ruokonen, A., Rudan, I., Rose, L. M., Roberts, R., Rieder, M., Psaty, B. M., Pramstaller, P. P., Pichler, I., Perola, M., Penninx, B. W., Pedersen, N. L., Pattaro, C., Parker, A. N., Pare, G., Oostra, B. A., O‘Donnell, C. J., Nieminen, M. S., Nickerson, D. A., Montgomery, G. W., Meitinger, T., McPherson, R., McCarthy, M. I., McArdle, W., Masson, D., Martin, N. G., Marroni, F., Mangino, M., Magnusson, P. K., Lucas, G., Luben, R., Loos, R. J., Lokki, M. L., Lettre, G., Langenberg, C., Launer, L. J., Lakatta, E. G., Laaksonen, R., Kyvik, K. O., Kronenberg, F., König, I. R., Khaw, K. T., Kaprio, J., Kaplan, L. M., Johansson, A., Jarvelin, M. R., Janssens, A. C., Ingelsson, E., Igl, W., Kees Hovingh, G., Hottenga, J. J., Hofman, A., Hicks, A. A., Hengstenberg, C., Heid, I. M., Hayward, C., Havulinna, A. S., Hastie, N. D., Harris, T. B., Haritunians, T., Hall, A. S., Gyllensten, U., Guiducci, C., Groop, L. C., Gonzalez, E., Gieger, C., Freimer, N. B., Ferrucci, L., Erdmann, J., Elliott, P., Ejebe, K. G., Döring, A., Dominiczak, A. F., Demissie, S., Deloukas, P., de Geus, E. J., de Faire, U., Crawford, G., Collins, F. S., Chen, Y. D., Caulfield, M. J., Campbell, H., Burtt, N. P., Bonnycastle, L. L., Boomsma, D. I., Boekholdt, S. M., Bergman, R. N., Barroso, I., Bandinelli, S., Ballantyne, C. M., Assimes, T. L., Quertermous, T., Altshuler D., Seielstad, M., Wong, T. Y., Tai, E. S., Feranil, A. B., Kuzawa, C. W., Adair, L. S., Taylor, H. A. Jr., Borecki, I. B., Gabriel, S. B., Wilson, J. G., Holm, H., Thorsteinsdottir, U., Gudnason. V., Krauss, R. M., Mohlke, K. L., Ordovas, J. M., Munroe, P. B., Kooner, J. S., Tall, A. R., Hegele, R. A., Kastelein, J. J., Schadt, E. E., Rotter, J. I., Boerwinkle, E., Strachan, D. P., Mooser, V., Stefansson, K., Reilly, M. P., Samani, N. J., Schunkert, H., Cupples, L. A., Sandhu, M. S., Ridker, P. M., Rader, D. J., van Duijn, C. M., Peltonen, L., Abecasis, G. R., Boehnke, M., Kathiresan, S. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713. <https://doi.org/10.1038/nature09270>
49. Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, Sarwar, N., Sandhu, M. S., Ricketts, S. L., Butterworth, A. S., Di Angelantonio, E., Boekholdt, S. M., Ouwehand, W., Watkins, H., Samani, N. J., Saleheen, D., Lawlor, D., Reilly, M. P., Hingorani, A. D., Talmud, P. J., Danesh, J. (2010) Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 375, 1634-1639. Erratum in: Lancet (2010) 376, 90. Kastelein, J. J. [added].
50. Visvikis-Siest, S., Aldasoro Arguinano, A. A., Stathopoulou, M., Xie, T., Petrelis, A., Weryha, G., Froguel, P., Meier-Abt, P., Meyer, U. A., Mlakar, V., Ansari, M., Papassotiropoulos, A., Dedoussis, G., Pan, B., Bühlmann, R. P., Noyer- Weidner, M., Dietrich, P. Y., Van Schaik, R., Innocenti, F., März, W., Bekris, L.M., Deloukas, P. (2017) 8th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3-5 October 2016. Drug. Metab. Pers. Ther. 32, 119-127. <https://doi.org/10.1515/dmpt-2017-0011>
51. Vrablík, M., Hořínek, A., Češka, R., Adámková, V., Poledne, R., Hubacek, J. A. (2003) Ser19→Trp polymorphism within the apolipoprotein AV gene in hypertriglyceridaemic people. J. Med. Genet. 40, e105. <https://doi.org/10.1136/jmg.40.8.e105>
52. Vrablik, M., Hubacek, J. A. (2010) Genetic determination of triglyceridemia with special focus on apolipoprotein gene variants. Clin. Lipidol. 5, 543-554. <https://doi.org/10.2217/clp.10.38>
53. Weber, K. S., Knebel, B., Strassburger, K., Kotzka, J., Stehle, P., Szendroedi, J., Müssig, K., Buyken, A. E., Roden, M., GDS Group. (2016) Associations between explorative dietary patterns and serum lipid levels and their interactions with ApoA5 and ApoE haplotype in patients with recently diagnosed type 2 diabetes. Cardiovasc. Diabetol. 15, 138. <https://doi.org/10.1186/s12933-016-0455-9>
54. Zlatohlavek, L., Vrablik, M., Ceska, R., Adamkova, V., Urbanova, Z., Prusikova, M., Vasickova, L., Hubacek, J. A. (2012) APOA5 haplotypes determine triglyceride decrease after lifestyle induced weight loss in children. Nutr. Metab. Cardiovasc. Dis. 22, e22-e23. <https://doi.org/10.1016/j.numecd.2012.05.001>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive